Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neuroscience: Standard model.

× No keyword cloud information.

32 in total

1. Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system.

Authors: Xiufang Guo; Mercedes Gonzalez; Maria Stancescu; Herman H Vandenburgh; James J Hickman
Journal: Biomaterials Date: 2011-09-23 Impact factor: 12.479

2. Identification of rat respiratory mucosa stem cells and comparison of the early neural differentiation potential with the bone marrow mesenchymal stem cells in vitro.

Authors: Xin Gao; Jian Zhang; Jun Zhang; Hongjun Zou; Jinbo Liu
Journal: Cell Mol Neurobiol Date: 2013-11-30 Impact factor: 5.046

3. FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.

Authors: Jelena Mojsilovic-Petrovic; Natalia Nedelsky; Marco Boccitto; Itzhak Mano; Savvas N Georgiades; Weiguo Zhou; Yuhong Liu; Rachael L Neve; J Paul Taylor; Monica Driscoll; Jon Clardy; Diane Merry; Robert G Kalb
Journal: J Neurosci Date: 2009-06-24 Impact factor: 6.167

Neuroscience: Standard model.

1. Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system.

2. Identification of rat respiratory mucosa stem cells and comparison of the early neural differentiation potential with the bone marrow mesenchymal stem cells in vitro.

3. FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.

4. Model organisms: There's more to life than rats and flies.

Review 5. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

6. Spineless solutions: The potential of invertebrate animal models for advancing science in the developing world.

Review 7. Institutional shared resources and translational cancer research.

8. Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations.

9. An in vitro screening cascade to identify neuroprotective antioxidants in ALS.

10. The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?